tiprankstipranks
Cannapharmarx Inc (CPMD)
OTHER OTC:CPMD
US Market

Cannapharmarx (CPMD) Stock Price & Analysis

55 Followers

CPMD Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.03
Previous Close$0.02
Volume1.67M
Average Volume (3M)2.39M
Market Cap
$5.07M
Enterprise Value$16.75M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$10.77M
Price to Earnings (P/E)-0.6
Beta-3210.91
May 14, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding337,961,136
10 Day Avg. Volume2,110,256
30 Day Avg. Volume2,394,625
Standard Deviation763.35
R-Squared0.00687
Alpha112.40
Financial Highlights & Ratios
Price to Book (P/B)-0.24
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)11.30
P/FCF Ratio2.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.29
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

8.78%0.00%0.00%91.22%
8.78%
Insiders
0.00% Other Institutional Investors
91.22% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

CPMD FAQ

What was Cannapharmarx Inc’s price range in the past 12 months?
Cannapharmarx Inc lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
    What is Cannapharmarx Inc’s market cap?
    Currently, no data Available
    When is Cannapharmarx Inc’s upcoming earnings report date?
    Cannapharmarx Inc’s upcoming earnings report date is May 14, 2024 which is in 46 days.
      How were Cannapharmarx Inc’s earnings last quarter?
      Currently, no data Available
      Is Cannapharmarx Inc overvalued?
      According to Wall Street analysts Cannapharmarx Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Cannapharmarx Inc pay dividends?
        Cannapharmarx Inc does not currently pay dividends.
        What is Cannapharmarx Inc’s EPS estimate?
        Cannapharmarx Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Cannapharmarx Inc have?
        Cannapharmarx Inc has 337,961,150 shares outstanding.
          What happened to Cannapharmarx Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Cannapharmarx Inc?
          Currently, no hedge funds are holding shares in CPMD
          ---

          Cannapharmarx Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          20 days / 200 days
          Momentum
          54.54%
          12-Months-Change

          Fundamentals

          Return on Equity
          Trailing 12-Months
          Asset Growth
          -4.88%
          Trailing 12-Months

          Company Description

          Cannapharmarx Inc

          CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. It focuses on the treatment of disease states such as neurological disorders, oncology, infectious disease, pain management, inflammatory disease, gastrointestinal disorders, and ophthalmology. The company was founded in August 1998 and is headquartered in Kelowna, Canada.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Aurora Cannabis
          Cronos Group
          Tilray
          CNBX Pharmaceuticals
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis